Department of Pharmacology

Newsletter


Hamm’s research honored by Dutch pharmacology society  Reporter  10/25/2012  Heidi Hamm, Ph.D., chair of the Department of Pharmacology, has won the 2012 Ariens Award from the Dutch Pharmacological Society.



 

Nobel in Chemistry reveals VU ties that bind
Vanderbilt Reporter  10/18/2012

Vanderbilt University researchers have good reason to feel proud about this year’s Nobel Prize in Chemistry, awarded last week to scientists at Duke and Stanford universities.

 

 

 


VU, Bristol-Myers to collaborate on Parkinson’s therapies
Vanderbilt Reporter  9/21/2012

Vanderbilt University and Bristol-Myers Squibb have signed a collaboration agreement for the discovery, development and commercialization of novel therapies acting on the mGluR4 glutamate receptor, known as positive allosteric modulators, or PAMs, for the treatment of Parkinson’s disease.



Conte Center receives grant to study serotonin.
Vanderbilt Reporter  8/30/2012

The Silvio O. Conte Center for Neuroscience Research at Vanderbilt has received a $10.5 million federal grant to continue its groundbreaking research on serotonin signaling in the brain for another five years.

 

 


Clues to retinal cell degeneration.
Vanderbilt Reporter  8/28/2012

Loss of photoreceptor cells (special neurons in the retina that convert light into biological signals) may be caused by defects in the response of the light receptor rhodopsin.


Little evidence supports autism treatment options in adolescents. 
Vanderbilt Reporter  8/27/2012

Vanderbilt University researchers studying interventions for adolescents and young adults with autism are reporting today that there is insufficient evidence to support findings, good or bad, for the therapies currently used.


VU, Lipscomb partner on dual degree program. 
Vanderbilt Reporter  8/23/2012

Rachel Crouch, Pharm.D., left, is the first student to pursue a Ph.D. at Vanderbilt as part of a new dual degree program with Lipscomb University’s College of Pharmacy.    (photo by Steve Green)


VU hosts international vascular biology research meeting.
Vanderbilt Reporter  8/2/2012

More than 100 students, faculty and scientists from around the world attended a four-day program on vascular biology research last week at Vanderbilt University.


Vanderbilt-led team to develop ‘microbrain’ to improve drug testing. Research News @ Vanderbilt  Tuesday, Jul. 24, 2012.  The work is also featured in the Nashville TennesseanMSNBC NewsPopular Scienceand WPLN-FM News.

 

 


 

VU study finds stress fuels breast cancer metastasis to bone.
Vanderbilt Reporter  5/18/2012

Florent Elefteriou, Ph.D., right, Preston Campbell and colleagues are investigating the role of stress in priming the bone environment for breast cancer cell metastasis. (photo by John Russell)


Vanderbilt University’s Jeffrey Conn, Ph.D., has won the first Governor’s Award for Innovation Excellence for his efforts to accelerate the discovery of new drugs for Parkinson’s disease, schizophrenia and other brain disorders.  Conn, who directs the Vanderbilt Center for Neuroscience Drug Discovery (VCNDD), received the award last week from Tennessee Governor Bill Haslam.  The award recognizes Tennesseans “whose dedication to enhancing our world through innovation has made a major impact on society.” Reporter  5/03/2012

 


Elaine Sanders-Bush, Ph.D., left, shares a laugh with Li-Huei Tsai, Ph.D., DVM, director of the Picower Institute for Learning and Memory at the Massachusetts Institute of Technology. Tsai was at Vanderbilt to deliver the 2012 Elaine Sanders-Bush Lecture, titled, “Restoring memory formation following neurodegeneration-mediated cognitive impairment.” Reporter 5/24/2012

 

 


Common antibiotic found to pose increased heart risk.  Vanderbilt researchers have discovered a rare, but important risk posed by the antibiotic azithromycin, commonly called a “Z-pack,” finding a 2.5-fold higher risk of death from cardiac arrhythmia in the first five days of taking azithromycin when compared with another common antibiotic or no antibiotics at all.  Wayne A. Ray, Ph.D., professor of Preventive Medicine, and C. Michael Stein, M.B., Ch.B., the Dan May Chair in Medicine and professor of Pharmacology, collaborated on the research published in the New England Journal of Medicine. Reporter 5/17/2012


New clue to ADHD.
Vanderbilt Reporter  5/15/20

Attention deficit hyperactivity disorder (ADHD) has been linked to alterations in the production, release and signaling of the neurotransmitter dopamine. Genetic changes that support these alterations, however, have been difficult to associate with specific molecular insults.


Roden’s research lauded by Heart Rhythm Society. Dan Roden, M.D., assistant vice chancellor for Personalized Medicine, has been named to receive the Heart Rhythm Society’s Douglas P. Zipes Lectureship Award.  He presented the lecture “Heart to Heart: Treating Arrhythmias Using Personalized Medicine” at the society’s 33rd annual Scientific Sessions in Boston. Reporter 5/10/2012

 

 


Vanderbilt takes center stage at TEDxNashville

Jeff Conn, Ph.D., presented “Breakthrough Medicines for Serious Brain Disorders” at TEDxNashville conference. Reporter 4/05/2012

http://www.youtube.com/watch?v=Lx27gzXLDic